Affinity Asset Advisors, LLC Q1 2021 Filing
Filed May 14, 2021
Portfolio Value
$294.5B
Holdings
70
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (70 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 110,000 | $43.6B | 14.81% | Put |
| 2 | BBIOBRIDGEBIO PHARMA INC | 577,500 | $35.6B | 12.08% | |
| 3 | ARKGARK ETF TR | 240,000 | $21.3B | 7.23% | Put |
| 4 | —CURIS INC | 1,250,000 | $14.2B | 4.81% | Call |
| 5 | MORFMORPHIC HLDG INC | 195,000 | $12.3B | 4.19% | |
| 6 | VRTXVERTEX PHARMACEUTICALS INC | 50,000 | $10.7B | 3.65% | Call |
| 7 | —VINCERX PHARMA INC | 543,010 | $10.5B | 3.56% | |
| 8 | KURAKURA ONCOLOGY INC | 365,000 | $10.3B | 3.50% | |
| 9 | —ARYA SCIENCES ACQUISITION CO | 689,000 | $9.5B | 3.22% | |
| 10 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $7.3B | 2.49% | |
| 11 | XLRNACCELERON PHARMA INC | 45,000 | $6.1B | 2.07% | |
| 12 | ACRSACLARIS THERAPEUTICS INC | 222,267 | $5.6B | 1.90% | |
| 13 | TVTXTRAVERE THERAPEUTICS INC | 220,000 | $5.5B | 1.87% | |
| 14 | NARIUSDINARI MED INC | 50,000 | $5.3B | 1.82% | |
| 15 | ASNDASCENDIS PHARMA A/S | 40,000 | $5.2B | 1.75% | Put |
| 16 | SNDXSYNDAX PHARMACEUTICALS INC | 190,500 | $4.3B | 1.45% | Call |
| 17 | TVTX 2.5 09/15/25RETROPHIN INC | 4,000,000 | $4.1B | 1.38% | |
| 18 | —LIFESCI ACQUISITION II CORP | 400,000 | $4.1B | 1.38% | |
| 19 | RCKTROCKET PHARMACEUTICALS INC | 85,000 | $3.8B | 1.28% | |
| 20 | OCULOCULAR THERAPEUTIX INC | 227,500 | $3.7B | 1.27% | |
| 21 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 270,000 | $3.7B | 1.26% | |
| 22 | ALDXALDEYRA THERAPEUTICS INC | 300,000 | $3.6B | 1.21% | |
| 23 | ZNTLZENTALIS PHARMACEUTICALS INC | 77,500 | $3.4B | 1.14% | |
| 24 | HZNPHORIZON THERAPEUTICS PUB L | 35,000 | $3.2B | 1.09% | |
| 25 | MREOMEREO BIOPHARMA GROUP PLC | 900,000 | $3.0B | 1.03% | |
| 26 | —MEDICUS SCIENCES ACQUISITION | 300,000 | $3.0B | 1.00% | |
| 27 | 290ACHINOOK THERAPEUTICS INC | 175,000 | $2.7B | 0.92% | |
| 28 | —CYCLACEL PHARMACEUTICALS INC | 380,000 | $2.7B | 0.92% | |
| 29 | TCE2CELLDEX THERAPEUTICS INC NEW | 130,000 | $2.7B | 0.91% | |
| 30 | EPIEURESSA PHARMA INC | 90,000 | $2.6B | 0.89% | |
| 31 | KALVKALVISTA PHARMACEUTICALS INC | 100,000 | $2.6B | 0.87% | |
| 32 | —ZYMEWORKS INC | 80,000 | $2.5B | 0.86% | |
| 33 | —HEALTH SCIENCES ACQ CORP 2 | 225,000 | $2.5B | 0.86% | |
| 34 | LUNGPULMONX CORP | 45,000 | $2.1B | 0.70% | |
| 35 | SWTXSPRINGWORKS THERAPEUTICS INC | 27,000 | $2.0B | 0.67% | |
| 36 | RUBYUSDRUBIUS THERAPEUTICS INC | 70,000 | $1.9B | 0.63% | Call |
| 37 | STROSUTRO BIOPHARMA INC | 80,000 | $1.8B | 0.62% | |
| 38 | —HIGHCAPE CAP ACQUISITION COR | 150,000 | $1.8B | 0.61% | |
| 39 | BFLYBUTTERFLY NETWORK INC | 100,000 | $1.7B | 0.57% | |
| 40 | —BLUEBIRD BIO INC | 50,000 | $1.5B | 0.51% | Call |
| 41 | —MERSANA THERAPEUTICS INC | 85,000 | $1.4B | 0.47% | |
| 42 | PTGXPROTAGONIST THERAPEUTICS INC | 50,000 | $1.3B | 0.44% | |
| 43 | BLUBELLUS HEALTH INC NEW | 300,000 | $1.2B | 0.39% | |
| 44 | IMVTIMMUNOVANT INC | 70,000 | $1.1B | 0.38% | Call |
| 45 | —BCTG ACQUISITION CORP | 100,000 | $1.1B | 0.38% | |
| 46 | GLPGGALAPAGOS NV | 12,500 | $964.0M | 0.33% | |
| 47 | CYTKCYTOKINETICS INC | 40,000 | $930.0M | 0.32% | |
| 48 | —VINCERX PHARMA INC | 218,000 | $881.0M | 0.30% | |
| 49 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 20,000 | $815.0M | 0.28% | |
| 50 | AFIBACUTUS MED INC | 60,000 | $802.0M | 0.27% | |
| 51 | MGNXMACROGENICS INC | 25,000 | $796.0M | 0.27% | |
| 52 | —CHARDAN HEALTHCR ACQSTN 2 CO | 75,000 | $789.0M | 0.27% | |
| 53 | IOVAIOVANCE BIOTHERAPEUTICS INC | 24,600 | $779.0M | 0.26% | |
| 54 | CCCCC4 THERAPEUTICS INC | 20,000 | $740.0M | 0.25% | |
| 55 | —ASLAN PHARMACEUTICALS LTD | 200,000 | $670.0M | 0.23% | |
| 56 | MRNAMODERNA INC | 5,000 | $655.0M | 0.22% | Call |
| 57 | ASNSUSDX4 PHARMACEUTICALS INC | 75,000 | $646.0M | 0.22% | |
| 58 | ESTAESTABLISHMENT LABS HLDGS INC | 10,000 | $625.0M | 0.21% | |
| 59 | PCVXVAXCYTE INC | 30,000 | $593.0M | 0.20% | |
| 60 | IMTXIMMATICS N.V | 200,000 | $590.0M | 0.20% | |
| 61 | AXSMAXSOME THERAPEUTICS INC | 10,000 | $566.0M | 0.19% | |
| 62 | BYSIBEYONDSPRING INC | 50,000 | $554.0M | 0.19% | |
| 63 | —EPIZYME INC | 50,000 | $436.0M | 0.15% | |
| 64 | —HARPOON THERAPEUTICS INC | 20,000 | $418.0M | 0.14% | |
| 65 | 698ACHILLES THERAPEUTICS PLC | 25,000 | $414.0M | 0.14% | |
| 66 | CTMXCYTOMX THERAPEUTICS INC | 50,000 | $387.0M | 0.13% | |
| 67 | —CEREVEL THERAPEUTICS HLDNG I | 72,466 | $312.0M | 0.11% | |
| 68 | WINTWINDTREE THERAPEUTICS INC | 42,847 | $105.0M | 0.04% | |
| 69 | —VESPER HEALTHCARE ACQSTN COR | 45,000 | $94.0M | 0.03% | |
| 70 | —ZYNERBA PHARMACEUTICALS INC | 13,285 | $62.0M | 0.02% |